Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
China Shineway Pharmaceutical Group Ltd
C1SChina Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd. Address: No. 168, Shiluan Street, Shijiazhuang, China, 051430
Analytics
WallStreetin tavoitehinta
88.80 HKDP/E-suhde
7.25Osinkotuotto
7.46 %Avainluvut C1S
- Käyttökate
- Kokonaistulot
- Bruttovoitto
- Nettotulos
Osinkoanalytiikka C1S
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y>5 - expected 5-9 dividend yield on cost over 10Y<5 - expected <5 dividend yield on cost over 10YMaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–Osinkojen kasvu 5 vuoden aikana
123.00 %Jatkuva kasvu
2 vuottaMaksusuhde 5 vuoden keskiarvo
57.00 %Osinkohistoria C1S
- Maksusuhde
- Dividends
- Osinkotuotto
Osakkeen arvostus C1S
- Hinta/tulot
- PE-suhde
- Hinta/kirjanpitoarvo
- Nykyinen likviditeettisuhde
- Velkasuhde
Talousasiat C1S
Tuloksia | 31.12.2015 | 31.12.2016 | 31.12.2017 | 31.12.2018 | 31.12.2019 | 31.12.2020 | 31.12.2021 | 31.12.2022 | 31.12.2023 | 31.12.2024 | Dynamiikka | |
Kokonaistulot | 2 057 075 492 HKD | 1 995 577 727 HKD | 1 921 725 359 HKD | 2 573 030 973 HKD | 2 708 980 763 HKD | 2 658 630 284 HKD | 3 227 105 633 HKD | 3 954 993 622 HKD | 4 521 519 820 HKD | 4 521 519 820 HKD * | ||
Toimintavoitto | 614 865 455 HKD | 565 221 762 HKD | 408 518 104 HKD | 494 841 212 HKD | 477 005 560 HKD | 422 863 908 HKD | 534 954 410 HKD | 714 363 085 HKD | 971 165 033 HKD | 971 165 033 HKD * | ||
Nettotulos - (CF) | 658 631 679 HKD | 589 845 892 HKD | 452 051 069 HKD | 506 433 984 HKD | 503 704 980 HKD | 295 358 425 HKD | 557 288 020 HKD | 723 570 227 HKD | 970 579 384 HKD | 970 579 384 HKD * | ||
Normalisoitu perus-EPS | 0.10 HKD | 0.09 HKD | 0.07 HKD | 0.08 HKD | 0.08 HKD | 0.05 HKD | 0.09 HKD | 0.12 HKD | 0.17 HKD | 0.17 HKD * | ||
Osinkotuotto | 0.26 HKD | 0.24 HKD | 0.27 HKD | 0.28 HKD | 0.26 HKD | 0.25 HKD | 0.72 HKD | 0.38 HKD | 0.47 HKD | 0.58 HKD | ||
Maksusuhde | 32.47 % | 33.06 % | 48.55 % | 44.54 % | 40.45 % | 65.28 % | 97.37 % | 40.02 % | 36.69 % | 45.25 % | ||
Kokonaisvarat | 6 159 888 983 HKD | 6 472 393 301 HKD | 6 672 464 739 HKD | 6 739 216 289 HKD | 7 139 207 000 HKD | 7 221 464 630 HKD | 7 211 904 103 HKD | 8 240 940 895 HKD | 9 584 553 289 HKD | 9 584 553 289 HKD * | ||
Kokonaisvelat | 858 076 430 HKD | 839 513 972 HKD | 845 089 120 HKD | 967 075 520 HKD | 1 355 907 938 HKD | 1 420 891 538 HKD | 1 303 913 656 HKD | 1 851 374 848 HKD | 2 542 025 808 HKD | 2 542 025 808 HKD * | ||
Velkasuhde | 0.14 | 0.13 | 0.13 | 0.14 | 0.19 | 0.20 | 0.18 | 0.23 | 0.27 | 0.27 * | ||
Kokonaiskäyttöpääoma | 3 844 727 129 HKD | 4 255 684 922 HKD | 4 565 323 083 HKD | 4 658 077 286 HKD | 5 208 792 065 HKD | 5 525 124 597 HKD | 5 705 398 226 HKD | 6 789 880 111 HKD | 8 163 724 817 HKD | 8 163 724 817 HKD * | ||
Kokonaiskäyttövelat | 702 381 879 HKD | 673 798 389 HKD | 710 075 361 HKD | 781 133 653 HKD | 1 179 306 360 HKD | 1 196 009 761 HKD | 1 099 582 519 HKD | 1 667 430 179 HKD | 2 436 402 430 HKD | 2 436 402 430 HKD * | ||
Nykyinen likviditeettisuhde | 5.47 | 6.32 | 6.43 | 5.96 | 4.42 | 4.62 | 5.19 | 4.07 | 3.35 | 3.35 * | ||
Pikavirtasuhde | 4.99 | 5.88 | 6.03 | 5.44 | 4.05 | 4.25 | 4.65 | 3.68 | 2.98 | 2.98 * | ||
Oman pääoman tuotto | 10.69 % | 9.11 % | 6.77 % | 7.51 % | 7.06 % | 4.09 % | 7.73 % | 8.78 % | 10.13 % | 10.13 % * | ||
FFO korkojen kattavuus | 10 068.82 | 5.24 | 4.01 | 3.60 | 175.97 | 24.91 | 416.85 | 1 114.88 | 456.13 | 456.13 * | ||
P/E-suhde - P/E (LTM) | 12.45 | 12.38 | 13.28 | 12.21 | 11.43 | 13.65 | 9.32 | 7.91 | 5.63 | 5.63 * | ||
Osinkotuotto (LTM) | 2.61 % | 2.67 % | 3.66 % | 3.65 % | 3.54 % | 4.78 % | 10.45 % | 5.06 % | 6.51 % | 6.01 % | ||
Takaisinoston tuotto (LTM) | - | - | - | 1.10 % | 4.51 % | 3.10 % | - | - | - | - |